国际标准期刊号: E-2314-7326
P-2314-7334

神经传染病

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Quantitative EEG Analysis in COVID-19 Encephalopathy: Promising Findings from a Case Report

Naro Antonino, Billeri Luana, Corpina Flavio, Ferlazzo Marco, Criaco Fabio, Fugazzotto Domenico

Objective: Tracking cognitive impairment in patients with coronavirus disease 2019 (COVID-19) requires objective markers to monitor therapy responses and prognosticate neurological recovery. We sought to assess if quantitative EEG (QEEG) analysis could help identifying peculiar features suggesting COVID-19 related encephalopathy regardless of brain damage related to pulmonary failure.

Methods: A patient, who survived to a severe respiratory failure due to COVID-19 pneumonia, developed a severe neurocognitive syndrome. The patient underwent QEEG monitoring (global coherence, GC) before after one month of intensive cardiopulmonary and motor rehabilitation.

Results: We found a high-frequency strong central-temporal-parietal connectivity at baseline. This was replaced by low-frequency frontal-parietal connectivity. EEG signals and their modifications were unrelated to the former acute respiratory failure.

Conclusion: A decrease of front parietal GC in the upper alpha and beta band in resting state may be a key feature of COVID-19-related encephalopathy. This may depend on a virus-induced brain damage causing loss of connections that are essential to orchestrate the interactions between brain regions at a global level concerning cognitive functions. Significance: Our data suggest that assessing GC seems promising to evidence a frontoparietal connectivity impairment sustaining the COVID-19 neurocognitive syndrome. Once confirmed in larger samples, these QEEG findings may support clinicians in the management and prognosis of COVID-19 patients.